Axon Enterprise Beats Q2 Estimates, Raises 2026 Revenue Outlook

What happened

Axon Enterprise reported second-quarter revenue of $904 million, representing 35% year-over-year growth and surpassing the consensus estimate of $876.4 million. Non-GAAP earnings per share came in at $1.88, slightly above the expected $1.84. The company raised its full-year revenue growth guidance to a range of 32–34%, up from the prior 30–32% outlook, while maintaining its adjusted EBITDA margin target of 25.5%. Software and Services revenue grew 36% to $398 million, though gross margin in that segment fell to 71.3% from 75.6% due to a heavier mix of professional services and scaling costs for newer products. Connected Devices revenue reached $507 million, with gross margin improving to 51.9% from 48.6%. Annual recurring revenue hit $1.6 billion, up 39%, and future contracted bookings rose 41% to $15.1 billion. Platform solutions, including the drone business, surged 123% to $149.8 million, and the AI Era subscription plan saw 700% growth. Adjusted EBITDA climbed 40% to $242 million, benefiting in part from global tariff refunds. GAAP EPS was reported at $0.29, down from prior levels due to a large tax benefit booked a year earlier. Free cash flow was negative $1 million for the quarter.

Why it matters

The results demonstrate Axon's ability to sustain high revenue growth for the tenth consecutive quarter above 30%, driven by strong demand across TASER devices, software subscriptions, and emerging platforms like drones and AI tools. The 39% increase in annual recurring revenue and 126% net revenue retention underscore the stickiness of Axon's software ecosystem and the expanding footprint of its public safety platform. However, the drop in software gross margin to 71.3% from 75.6% signals near-term profitability pressure as the company scales newer products and absorbs higher professional services costs. The raised full-year guidance reflects management confidence in demand momentum, yet the stock's decline following the report highlights investor sensitivity to margin compression and valuation concerns. With the stock trading at roughly 15× sales and a price-to-earnings ratio near 100 on adjusted figures, even a strong beat and guidance raise were not enough to sustain momentum, underscoring the market's focus on operational efficiency alongside top-line growth.

Bigger picture

Axon is transitioning from a hardware-centric TASER manufacturer into a software and data platform for public safety, a shift that positions it within the broader SaaS and AI infrastructure landscape. The 700% growth in AI Era subscriptions and 123% surge in platform solutions reflect the company's push into AI-driven tools and drone technology, areas with high strategic value but also execution risk. The recent volatility in SaaS stocks, sometimes referred to as the SaaSpocalypse, has led investors to reassess software valuations, particularly for companies trading at premium multiples. While Axon is less exposed to disruption from AI-native competitors than traditional enterprise SaaS firms, its valuation implies aggressive growth expectations that leave little room for margin setbacks or budget constraints in public safety spending. The stock's 230.1% five-year total return contrasts with a 29.4% decline over the past year, illustrating how sentiment has shifted as the market reprices growth stocks. A Discounted Cash Flow analysis pegs intrinsic value at approximately $421 per share, implying a 44.6% overvaluation at recent prices, though this relies on assumptions of sustained cash flow growth over the next decade.

What to watch

Investors should monitor whether software gross margins stabilise or continue to compress as Axon scales newer AI and drone offerings, and whether professional services costs can be offset by pricing or operational leverage. The trajectory of annual recurring revenue and net revenue retention will signal whether the platform's stickiness holds as competition or budget pressures emerge. Future contracted bookings, which grew 41% to $15.1 billion, provide visibility into demand, but conversion to revenue and cash flow will be critical. Watch for updates on free cash flow generation, which turned negative $1 million this quarter, and whether Axon can meet its 25.5% adjusted EBITDA margin target while investing in growth. Any changes to public safety budgets, regulatory tailwinds, or competitive dynamics in the evidence management and AI tool markets could materially affect the growth outlook embedded in current valuations.